The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 5,901–6,000 of 31,469
Araújo, S., Bañón, S., Machuca, I., Moreno, A. M., Pérez-Elías, M. J., & Casado, J. L. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0337 · Cited by 64
Yang, Z. H., Wen, J., Tao, X., Lü, B., Du, Y., Wang, M., Wang, X., Zhang, W., Gong, W., Ling, C., et al. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0212-1 · Cited by 60
Hyperinsulinemia in newly diagnosed patients with multiple sclerosis
Penesová, A., Vlček, M., Imrich, R., Vernerová, L., Marko, A., Meskova, M., Grunnerova, L., Turčáni, P., Ježová, D., & Kollár, B. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9665-1 · Cited by 60
Association between endogenous secretory RAGE, inflammatory markers and arterial stiffness
Choi, K. M., Yoo, H. J., Kim, H. Y., Lee, K. W., Seo, J. A., Kim, S. G., Kim, N. H., Choi, D. S., & Baik, S. H. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.10.047 · Cited by 63
Choi, J. S., Koh, I.-U., Jung, M. H., & Song, J. (2007) · British Journal Of Nutrition · doi:10.1017/s000711450770497x · Cited by 62
Kashiwagi, A., Akiyama, N., Shiga, T., Kazuta, K., Utsuno, A., Yoshida, S., & Ueyama, E. (2014) · Diabetology International · doi:10.1007/s13340-014-0184-9 · Cited by 60
Kim, Y.-H., Jung, S., Nam, G.-E., Han, K. D., Bok, A. R., Baek, S., Cho, K.-H., Choi, Y. S., Kim, S.-M., Ju, S.-Y., et al. (2014) · Eye · doi:10.1038/eye.2014.43 · Cited by 60
Κόλλιας, Α., Tsiotra, P. C., Ikonomidis, I., Maratou, E., Mitrou, P., Kyriazi, E., Boutati, E. I., Lekakis, J. P., Economopoulos, T., Kremastinos, D. T., et al. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-14 · Cited by 60
Kazankov, K., Tordjman, J., Møller, H. J., Vilstrup, H., Poitou, C., Bédossa, P., Bouillot, J., Clément, K., & Grønbæk, H. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12943 · Cited by 63
Effects of insulin resistance on white matter microstructure in middle-aged and older adults
Ryu, S. Y., Coutu, J., Rosas, H. D., & Salat, D. H. (2014) · Neurology · doi:10.1212/wnl.0000000000000452 · Cited by 60
Cannabis use in relation to obesity and insulin resistance in the inuit population
Ngueta, G., Bélanger, R. E., Laouan-Sidi, E. A., & Lucas, M. (2014) · Obesity · doi:10.1002/oby.20973 · Cited by 60
Li, X., Guo, Y.-R., Lin, J.-F., Feng, Y., Billig, H., & Shao, R. (2014) · Journal of Cancer · doi:10.7150/jca.8009 · Cited by 60
Reis, C. E. G., Ribeiro, D. N., Costa, N. M. B., Bressan, J., Alfenas, R. D. C. G., & Mattes, R. D. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512004217 · Cited by 62
Proinsulin Concentration Is an Independent Predictor of All-Cause and Cardiovascular Mortality
Alssema, M., Dekker, J. M., Nijpels, G., Stehouwer, C. D. A., Bouter, L. M., & Heine, R. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.860 · Cited by 59
Rosenstock, J., Goldstein, B. J., Vinik, A., O’Neill, M., Porter, L. E., Heise, M. A., Kravitz, B. G., Dirani, R. G., Freed, M. I., & and the RESULT Study Group (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00541.x · Cited by 60
Calleja, A. I., García-Bermejo, P., Cortijo, E., Bustamante, R., Martínez, E. R., Sarmiento, E. G., Fernández-Herranz, R., & Arenillas, J. F. (2011) · Diabetes Care · doi:10.2337/dc11-1242 · Cited by 60
Chao, L.-T., Wu, C. F., Sung, F.-Y., Lin, C., Liu, C., Huang, C.-J., Tsai, K., & Yu, M. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr058 · Cited by 60
Karelis, A. D., Pasternyk, S. M., Messier, L., St-Pierre, D. H., Lavoie, J.-M., Garrel, D. R., & RABASA-LHORET, R. P. R. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-095 · Cited by 60
Porter, S. A., Pedley, A., Massaro, J. M., Vasan, R. S., Hoffmann, U., & Fox, C. S. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300075 · Cited by 59
Kunutsor, S. K., Bakker, S. J. L., Kootstra‐Ros, J. E., Blokzijl, H., Gansevoort, R. T., & Dullaart, R. P. F. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.09.006 · Cited by 61
Seimon, R. V., Brennan, I. M., Russo, A., Little, T. J., Jones, K. L., Standfield, S., Wishart, J. M., Horowitz, M., & Feinle‐Bisset, C. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00533.2012 · Cited by 59
Pighon, A., Gutkowska, J., Jankowski, M., RABASA-LHORET, R. P. R., & Lavoie, J.-M. (2010) · Metabolism · doi:10.1016/j.metabol.2010.06.012 · Cited by 61
Insulin Resistance Is an Intrinsic Defect Independent of Fat Mass in Women with Turner’s Syndrome
Salgin, B., Amin, R., Yuen, K. C. J., Williams, R. M., Murgatroyd, P. R., & Dunger, D. B. (2006) · Hormone Research in Paediatrics · doi:10.1159/000090907 · Cited by 60
Obesity dynamics and cardiovascular risk factor stability in obese adolescents
Weiss, R., Shaw, M. M., Savoye, M., & Caprio, S. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00504.x · Cited by 60
Tovar, J., Nilsson, A. C., Johansson, M., & Björck, I. (2013) · British Journal Of Nutrition · doi:10.1017/s000711451300305x · Cited by 60
Sárközy, M., Zvara, Á., Gyémánt, N., Fekete, V., Kocsis, G. F., Pipis, J., Szűcs, G., Csonka, C., Puskás, L. G., Ferdinandy, P., et al. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-16 · Cited by 60
Steffin, B., Gutt, B., Bidlingmaier, M., Dieterle, C. D., Oltmann, F., & Schopohl, J. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02185 · Cited by 60
Kezirian, E. J., Malhotra, A., Goldberg, A. N., & White, D. P. (2010) · The Laryngoscope · doi:10.1002/lary.20946 · Cited by 61
C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study
Jeppesen, J., Hansen, T. W., Olsen, M. H., Rasmussen, S. L., lbsen, H., Torp-Pedersen, C. T., Hildebrandt, P. R., & Madsbad, S. (2008) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e328308bb8b · Cited by 60
Changes in Metabolic Health Status Over Time and Risk of Developing Type 2 Diabetes
Lee, S., Yang, H. K., Ha, H., Lee, J., Kwon, H., Park, Y., Yim, H., Kang, M., Lee, W., Son, H., et al. (2015) · Medicine · doi:10.1097/md.0000000000001705 · Cited by 60
Intermittent energy restriction induces changes in breast gene expression and systemic metabolism
Harvie, M., Sims, A. H., Pegington, M., Spence, K., Mitchell, A. J., Vaughan, A. A., Allwood, J. W., Yun Xu, A., Rattray, N. J. W., Goodacre, R., et al. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0714-4 · Cited by 59
Elevated levels of chemerin, leptin, and interleukin-18 in gestational diabetes mellitus
Fatima, S. S., Alam, F., Chaudhry, B., & Khan, T. A. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2016.1199671 · Cited by 61
Zhu, Y., Mendola, P., Albert, P. S., Bao, W., Hinkle, S. N., Tsai, M. Y., & Zhang, C. (2016) · Diabetes · doi:10.2337/db16-0514 · Cited by 59
Severe Periodontitis Is Associated with Insulin Resistance in Non-abdominal Obese Adults
Song, I., Han, K., Park, Y., Ji, S., Jun, S.-H., Ryu, J., & Park, J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2061 · Cited by 60
Santilli, F., Liani, R., Fulvio, P. D., Formoso, G., Simeone, P., Tripaldi, R., Ueland, T., Aukrust, P., & Davı̀, G. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-06-0471 · Cited by 62
Stefansson, V. T. N., Schei, J., Jenssen, T. G., Melsom, T., & Eriksen, B. O. (2016) · BMC Nephrology · doi:10.1186/s12882-016-0386-4 · Cited by 60
Metformin prevents metabolic side effects during systemic glucocorticoid treatment
Seelig, E., Meyer, S., Timper, K., Nigro, N., Bally, M. R., Pernicova, I., Schüetz, P., Müller, B., Korbonits, M., & Christ‐Crain, M. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0653 · Cited by 59
Leptin and adiponectin as predictors of cardiovascular risk after gestational diabetes mellitus
Lekva, T., Michelsen, A. E., Aukrust, P., Henriksen, T., Bollerslev, J., & Ueland, T. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0492-4 · Cited by 62
Castellano, C., Paquet, N., Dionne, I. J., Imbeault, H., Langlois, F., Croteau, É., Tremblay, S., Fortier, M., Matte, J. J., Lacombe, G., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161163 · Cited by 62
Reduced water intake deteriorates glucose regulation in patients with type 2 diabetes
Johnson, E. C., Bardis, C. N., Jansen, L. T., Adams, J. D., Kirkland, T. W., & Kavouras, S. A. (2017) · Nutrition Research · doi:10.1016/j.nutres.2017.05.004 · Cited by 67
Iki, M., Fujita, Y., Kouda, K., Yura, A., Tachiki, T., Tamaki, J., Winzenrieth, R., Sato, Y., Moon, J., Okamoto, N., et al. (2017) · Bone · doi:10.1016/j.bone.2017.08.007 · Cited by 61
Nyström, C. D., Henriksson, P., Martínez‐Vizcaíno, V., Medrano, M., Cadenas‐Sánchez, C., Arias-Palencia, N. M., Löf, M., Ruiz, J. R., Labayen, I., Sánchez‐López, M., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1334 · Cited by 60
Association of Androgen Excess with Glucose Intolerance in Women with Polycystic Ovary Syndrome
Zhang, B., Wang, J., Shen, S., Liu, J., Sun, J., Gu, T., Ye, X., Zhu, D., & Bi, Y. (2018) · BioMed Research International · doi:10.1155/2018/6869705 · Cited by 62
Fujimori, N., Umemura, T., Kimura, T., Tanaka, N., Sugiura, A., Yamazaki, T., Joshita, S., Komatsu, M., Usami, Y., Sano, K., et al. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i11.1239 · Cited by 61
Chen, V. C., Chen, C.-H., Chiu, Y.-H., Lin, T., Li, F.-C., & Lu, M. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.03.021 · Cited by 60
Childhood Adversity and Schizophrenia
Lee, E., Martin, A. S., Tu, X. M., Palmer, B. W., & Jeste, D. V. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17m11776 · Cited by 64
Niklowitz, P., Rothermel, J., Lass, N., Barth, A. C. R., & Reinehr, T. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0157-3 · Cited by 61
Biddle, G. J. H., Edwardson, C. L., Henson, J. J., Davies, M. J., Khunti, K., Rowlands, A. V., & Yates, T. E. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15102280 · Cited by 62
Fadaei, R., Moradi, N., Kazemi, T., Chamani, E., Azdaki, N., Moezibady, S. A., Shahmohamadnejad, S., & Fallah, S. (2018) · Cytokine · doi:10.1016/j.cyto.2018.09.019 · Cited by 60
Abdelmageed, M. E., Shehatou, G. S. G., Abdelsalam, R. A., Suddek, G. M., & Salem, H. A. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1583-4 · Cited by 64
Metabolic Obesity Phenotypes and Thyroid Cancer Risk: A Cohort Study
Kwon, H., Chang, Y., Cho, A., Ahn, J., Park, S. E., Park, C., Lee, W., Oh, K.-W., Park, S., Shin, H. C., et al. (2019) · Thyroid · doi:10.1089/thy.2018.0327 · Cited by 60
Rodríguez‐Calvo, R., Girona, J., Rodríguez, M. M., Samino, S., Barroso, E., de Gonzalo‐Calvo, D., Guaita‐Esteruelas, S., Heras, M., van der Meer, R. W., Lamb, H. J., et al. (2019) · Metabolism · doi:10.1016/j.metabol.2019.04.007 · Cited by 63
Asada, M., Oishi, E., Sakata, S., Hata, J., Yoshida, D., Honda, T., Furuta, Y., Shibata, M., Suzuki, K., Watanabe, H., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013628 · Cited by 60
Ganji, V., Tangpricha, V., & Zhang, X. (2020) · Nutrients · doi:10.3390/nu12030730 · Cited by 63
McIntyre, D. H., Peacock, A. S., Miller, Y. D., Koh, D., & Marshall, A. L. (2012) · International Journal of Endocrinology · doi:10.1155/2012/892019 · Cited by 60
Taniguchi, A., Fukushima, M., Sakai, M., Tokuyama, K., Nagata, I., Fukunaga, A., Kishimoto, H., Doi, K., Yamashita, Y., Matsuura, T., et al. (2001) · Metabolism · doi:10.1053/meta.2001.21028 · Cited by 60
Lewandowski, K. C., Szosland, K., O’Callaghan, C. J., Tan, B. K., Randeva, H. S., & Lewiñski, A. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.12.014 · Cited by 62
Weight Regain Following Sustained Weight Reduction is Predicted by Relative Insulin Sensitivity
Yost, T. J., Jensen, D. R., & Eckel, R. H. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00193.x · Cited by 60
POPOVIC, V. M., Doknić, M., Marić, N. P., Pekić, S., Damjanović, A., Miljić, D., Popović, S., Miljic, N., Djurovic, M. N., Jašović‐Gašić, M., et al. (2007) · Neuroendocrinology · doi:10.1159/000103868 · Cited by 60
Rossi, G. P., Cesari, M., Toni, R. D., et al. (2003) · Circulation · doi:10.1161/01.cir.0000097122.19430.48 · Cited by 60
Nonalcoholic fatty liver in patients with Laron syndrome and GH gene deletion – Preliminary report
Laron, Z., Ginsberg, S., & Webb, M. (2008) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2008.03.003 · Cited by 61
Chan, D. C., Watts, G. F., Ng, T., Yamashita, S., & Barrett, P. H. R. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02019.x · Cited by 62
Impact of the high‐molecular‐weight form of adiponectin on endothelial function in healthy young men
Torigoe, M., Matsui, H., Ogawa, Y., Murakami, H., Murakami, R., Cheng, X. W., Numaguchi, Y., Murohara, T., & Okumura, K. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02876.x · Cited by 59
Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment
Bugianesi, E., Marzocchi, R., Villanova, N., & Marchesini, G. (2004) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2004.06.025 · Cited by 61
The Plasminogen Activator System in Young and Lean Women with Polycystic Ovary Syndrome
Tarkun, İ., Cantürk, Z., ARSLAN, B., Türemen, E., & Tarkun, P. (2004) · Endocrine Journal · doi:10.1507/endocrj.51.467 · Cited by 61
Gravholt, C. H., Næraa, R. W., Brixen, K., Kastrup, K. W., Mosekilde, L., Jørgensen, J. O. L., & Christiansen, J. S. (2002) · PEDIATRICS · doi:10.1542/peds.110.5.889 · Cited by 61
Gambineri, A., Semple, R. K., Forlani, G., Genghini, S., Grassi, I., Hyden, C. S. S., Pagotto, U., O’Rahilly, S., & Pasquali, R. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0272 · Cited by 60
Common Genetic Determinants of Glucose Homeostasis in Healthy Children
Kelliny, C., Ekelund, U., Andersen, L. B., Brage, S., Loos, R. J. F., Wareham, N. J., & Langenberg, C. (2009) · Diabetes · doi:10.2337/db09-0374 · Cited by 59
Katsuki, A., Sumida, Y., Urakawa, H., Gabazza, E. C., Murashima, S., Morioka, K., Kitagawa, N., Tanaka, T., Araki-Sasaki, R., Hori, Y., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020486 · Cited by 60
Waist-hip ratio and low HDL predict the risk of coronary artery disease in Pakistanis
Nishtar, S., Wierzbicki, A. S., Lumb, P. J., Lambert‐Hammill, M., Turner, C., Crook, M. A., Mattu, M. A., Shahab, S., Badar, A., Ehsan, A., et al. (2003) · Current Medical Research and Opinion · doi:10.1185/030079903125002595 · Cited by 59
Familial aggregation of the metabolic syndrome in Korean families with adolescents
Park, H. S., Park, J. Y., & Cho, S. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.07.019 · Cited by 60
Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome
Checa, M. Á., Requena, A., Salvador, C., Tur, R., Callejo, J., Espinós, J. J., Fábregues, F., Herrero, J. C., & (Reproductive Endocrinology Interest Group of the Spanish Society of Fertility) (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi015 · Cited by 60
Gu, H. F., Efendić, S., Nordman, S., Östenson, C., Brismar, K., Brookes, A. J., & Prince, J. A. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2137 · Cited by 60
Ridderstråle, M., Carlsson, E., Klannemark, M., Cederberg, A., Kösters, C., Tornqvist, H. E., Storgaard, H., Vaag, A. A., Enerbäck, S., & Groop, L. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3554 · Cited by 60
In vivo regulation of plasma free fatty acids in insulin resistance
Mook, S., Halkes, C. J. M., Bilecen, S., & Cabezas, M. C. (2004) · Metabolism · doi:10.1016/j.metabol.2004.02.023 · Cited by 59
Improvement of Metabolism among Obese Breast Cancer Survivors in Differing Weight Loss Regimens
Jen, K. ‐. C., Djuric, Z., DiLaura, N. M., Buison, A., Redd, J. N., Maranci, V., & Hryniuk, W. M. (2004) · Obesity Research · doi:10.1038/oby.2004.38 · Cited by 59
van Koppen, A., Verschuren, L., van den Hoek, A. M., Verheij, J., Morrison, M. C., Li, K., Nagabukuro, H., Costessi, A., Caspers, M. P. M., van den Broek, T. J., et al. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.10.001 · Cited by 58
Moran, L. J., Hutchison, S. K., Meyer, C., Zoungas, S., & Teede, H. J. (2009) · Clinical Science · doi:10.1042/cs20080218 · Cited by 59
Phelan, N., O’Connor, A., Kyaw Tun, T., Correia, N., Boran, G., Roche, H. M., & Gibney, J. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.005538 · Cited by 89
Apelin Serum Level in Egyptian Patients with Chronic Hepatitis C
EL-Mesallamy, H. O., Hamdy, N. Μ., Rizk, H. H., & El‐Zayadi, A. (2011) · Mediators of Inflammation · doi:10.1155/2011/703031 · Cited by 60
Wu, B., Fukuo, K., Suzuki, K., Yoshino, G., & Kazumi, T. (2009) · Endocrine Journal · doi:10.1507/endocrj.k08e-332 · Cited by 60
Elevation of markers of endotoxemia in women with polycystic ovary syndrome
Banaszewska, B., Siakowska, M., Chudzicka-Strugała, I., Chang, R. J., Pawelczyk, L. A., Zwoździak, B., Spaczyński, R., & Dulęba, A. J. (2020) · Human Reproduction · doi:10.1093/humrep/deaa194 · Cited by 61
Implication of Heterozygous Variants in Genes of the Leptin–Melanocortin Pathway in Severe Obesity
Courbage, S., Poitou, C., Beyec, J. L., Karsenty, A., Lemale, J., Pelloux, V., Lacorte, J., Carel, J., Lecomte, N., Storey, C., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab404 · Cited by 60
Tejani, S., McCoy, C., Ayers, C. R., Powell-Wiley, T. M., Després, J.-P., Linge, J., Leinhard, O. D., Petersson, M., Borga, M., & Neeland, I. J. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.08.021 · Cited by 60
Gong, R., Luo, G., Wang, M., Ma, L., Sun, S., & Wei, X. (2021) · Endocrine Connections · doi:10.1530/ec-21-0414 · Cited by 65
Ma, R.-L., Deng, Y., Wang, Y.-F., Zhu, S.-Y., Ding, X.-S., & Sun, A.-J. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001712 · Cited by 90
Li, Z., Zhou, E., Liu, C., Wicks, H., Yildiz, S., Razack, F., Ying, Z., Kooijman, S., Koonen, D. P. Y., Heijink, M., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.166655 · Cited by 67
Park, S., Park, J. Y., Lee, J. H., & Kim, S. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0113 · Cited by 58
Palomba, S., Falbo, A. I., Russo, T., Battista, L., Tolino, A., Orio, F., & Zullo, F. (2010) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02525.x · Cited by 61
Peacock, A. S., Bogossian, F. E., Wilkinson, S. A., Gibbons, K. S., Kim, C., & McIntyre, H. D. (2015) · International Journal of Endocrinology · doi:10.1155/2015/423717 · Cited by 59
Qian, J., Yeh, B., Rakshit, K., Colwell, C. S., & Matveyenko, A. V. (2015) · Endocrinology · doi:10.1210/en.2015-1516 · Cited by 61
Blanc, E., Ponce, C., Brodschi, D., Nepote, A., Barreto, A., Schnitman, M., Fossati, P., Salgado, P., Cejas, C. P., Faingold, C., et al. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0158 · Cited by 59
Bradley, D. P., Magkos, F., Eagon, J. C., Varela, J. E., Gastaldelli, A., Okunade, A. L., Patterson, B. W., & Klein, S. (2014) · Obesity · doi:10.1002/oby.20803 · Cited by 59
Cuenca‐García, M., Ortega, F. B., Ruiz, J. R., González‐Gross, M., Labayen, I., Jago, R., Martínez‐Gómez, D., Dallongeville, J., Bel‐Serrat, S., Marcos, A., et al. (2012) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.12022 · Cited by 62
Peppa, Μ., Koliaki, C. C., Papaefstathiou, A., Garoflos, E., Katsilambros, N. L., Raptis, S., Hadjidakis, D. I., & Dimitriadis, G. (2013) · Obesity · doi:10.1002/oby.20227 · Cited by 58
From Metabolic Normality to Cardiometabolic Risk Factors in Subjects With Obesity
Bobbioni‐Harsch, E., Pataky, Z., Makoundou, V., Laville, M., Disse, E., Anderwald, C. H., Konrad, T., Golay, A., & On Behalf of the RISC Investigators (2012) · Obesity · doi:10.1038/oby.2012.69 · Cited by 59
Park, S. H., Kim, B. I., Kim, S. H., Kim, H. J., Park, D. I., Cho, Y. K., Sung, I. K., Sohn, C. I., Kim, H. Y., Keum, D. K., et al. (2007) · Journal of the American College of Nutrition · doi:10.1080/07315724.2007.10719618 · Cited by 59
High prevalence of cardio‐metabolic risk factors among adolescents with intellectual disability
Wallén, E. F., Müllersdorf, M., Christensson, K., Malm, G., Ekblom, Ö. B., & Marcus, C. (2009) · Acta Paediatrica · doi:10.1111/j.1651-2227.2008.01197.x · Cited by 59
Bourcier, M. E., Sherrod, A. M., DiGuardo, M. A., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0788 · Cited by 59
Mitochondrial diabetes: investigation and identification of a novel mutation.
Lynn, S., Wardell, T. M., Johnson, M. A., Chinnery, P. F., Daly, M., Walker, M., & Turnbull, D. M. (1998) · Diabetes · doi:10.2337/diabetes.47.11.1800 · Cited by 58
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
